A 2024 comparative cohort study by Alkabbani et al
The DCM cohort that was observed showed an increase of over 163% between the control and the DCM groups which used a total of 66 animals (SMD 1.87, 95%CI 0.95, 2.79, p = 0.0001)
is one of those big global pharma companies that keeps working on new medicines and healthcare products, across a bunch of therapeutic areas
Within the first week, the stiffness disappeared
In our current analysis of the STEP 1 data, we found evidence that semaglutide might lower CVD risk even in populations not enriched for multiple CVD risk factors or with established CVD (primary prevention)
You must move from arbitrage to precision. If you continue to mass-produce copies of Ozempic and Zepbound without meticulous patient-level clinical justification, you are inviting a lawsuit that will likely end your facility